Suppression of morphine-induced conditioned place preference by l-12-chloroscoulerine, a novel dopamine receptor ligand

Pharmacology Biochemistry and Behavior

Volumn 75, Issue 2, 2003, Pages 289-294

  Liu, Zhong Hua ^a   Jin, Wen Qiao ^a   Zhang, Hong Ping ^a   Chen, Xin Jian ^a   Jin, Guo Zhang ^a  

^a SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

Conditioned place preference; Dopamine receptors; l 12 Chloroscoulerine; Morphine; PPHT; SCH23390

Indexed keywords

12 CHLOROSCOULERINE; 12-CHLOROSCOULERINE; 2 (N PHENYLETHYL N PROPYL)AMINO 5 HYDROXYTETRALIN; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; BERBERINE DERIVATIVE; DOPAMINE 1 RECEPTOR; DOPAMINE 1 RECEPTOR BLOCKING AGENT; DOPAMINE 1 RECEPTOR STIMULATING AGENT; DOPAMINE 2 RECEPTOR; DOPAMINE 2 RECEPTOR BLOCKING AGENT; DOPAMINE 2 RECEPTOR STIMULATING AGENT; DOPAMINE RECEPTOR; DOPAMINE RECEPTOR BLOCKING AGENT; LEVO 12 CHLOROSCOULERINE; LIGAND; MORPHINE; NARCOTIC AGENT; NARCOTIC ANTAGONIST; UNCLASSIFIED DRUG;

ANIMAL; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; AVERSION; CONDITIONING; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; INSTRUMENTAL CONDITIONING; MALE; MOUSE; NONHUMAN; PLACE PREFERENCE; PRIORITY JOURNAL;

EID: 0038447003     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(03)00089-3     Document Type: Article

References (38)

1. Acquas E., Carboni E., Leone P., Di Chiara G. SCH 23390 blocks drug-conditioned place-preference and place aversion: anhedonia (lack of reward) or apathy (lack of motivation) after dopamine receptor blockade? Psychopharmacology. 99:1989;151-155.
2. Blander H., Hunt T., Blair T., Amit Z. Conditioned place preference: an evaluation of morphine's positive reinforcing properties. Psychopharmacology. 84:1984;124-127.
3. Chen L.J., Xi Y., Pang D.W., Zhou Q.T., Jin G.Z. Effect of (±)-12-chloroscoulerine on brain dopamine receptors. Acta Pharmacol. Sin. 17:1996;185-189.
4. 2 autoreceptors. Acta Pharmacol. Sin. 17:1996;477-480.
5. Chen L.J., Zhou Q.T., Dong Z.J., Yu L.P., Jin G.Z. Comparison of 12-chloroscoulerine enantiomers on animal behavior to dopamine receptors. Acta Pharmacol. Sin. 20:1999;884-888.
6. Di Chiara G., Imperato A. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc. Natl. Acad. Sci. U. S. A. 85:1988;5274-5278.
7. Guo G.W., Liu Z.H., Jin W.Q., Zhang H.P., Chen X.J., Zhu Y.C.et al. Quantitative comparison of ohmefentanyl isomers induced conditioning place preference in mice. Life Sci. 68:2001;2383-2390.
8. Hoffman D.C., Donovan H. Effects of typical, atypical, and novel antipsychotic drugs on amphetamine-induced place conditioning in rats. Drug Dev. Res. 36:1995;193-198.
9. Iorio L.C., Barnett A., Leitz F.H., Houser V.P., Korduba C.A. SCH 23390, a potential benzazepine antipsychotic with unique interactions on dopaminergic systems. J. Pharmacol. Exp. Ther. 226:1983;462-468.
10. Jin G.Z. Discoveries in the Voyage of Corydalis Research. 2001;Shanghai Scientific & Technical Publishers, Shanghai.
11. Jin W.Q., Zhang H.P., Chen X.J., Chi Z.Q. Effects of rotundine on morphine tolerance and dependence. Acad. Period Abstr. Chin. 4:1998;1136-1138.
12. Jin G.Z., Zhu Z.T., Fu Y. (-)-Stepholidine: a potential novel antipsychotic drug with dual D1 receptor agonist and D2 receptor antagonist actions. Trends Pharmacol. Sci. 23:2002;4-7.
13. Kivastik T., Vuorikallas K., Piepponen T.P., Zharkovsky A., Ahtee L. Morphine- and cocaine-induced conditioned place preference: effects of quinpirole and preclamol. Pharmacol. Biochem. Behav. 54:1996;371-375.
14. Koob G.F. Drugs of abuse: anatomy, pharmacology, and function of reward pathways. Trends Pharmacol. Sci. 13:1992;177-184.
15. Laviola G., Adriani W. Evaluation of unconditioned novelty-seeking and d-amphetamine-conditioned motivation in mice. Pharmacol. Biochem. Behav. 59:1998;1011-1020.
16. Leone P., Di Chiara G. Blockade of D-1 receptors by SCH23390 antagonizes morphine- and amphetamine-induced place preference conditioning. Eur. J. Pharmacol. 135:1987;251-254.
17. Mackey W.B., van der Kooy D. Neuroleptics block the positive reinforcing effects of amphetamine but not of morphine as measured by place conditioning. Pharmacol. Biochem. Behav. 22:1985;101-105.
18. Maldonado R., Saiardi A., Valverde A.O., Samad T.A., Roques B.P., Borrelli E. Absence of opiate rewarding effects in mice lacking dopamine D2 receptors. Nature. 388:1997;586-589.
19. Manzanedo C., Aguilar M.A., Rodriguez-Arias M., Minarro J. Effect of dopamine antagonists with different receptor blockade profiles on morphine-induced place preference in male mice. Behav. Brain Res. 121:2001;189-197.
20. Nomikos G.G., Spyraki C. Cocaine-induced place conditioning: importance of route of administration and other procedural variables. Psychopharmacology. 94:1988;119-125.
21. Rademacher D.J., Steinpreis R.E. Effects of the selective mu1-opioid receptor antagonist, naloxonazine, on cocaine-induced conditioned place preference and locomotor behavior in rats. Neurosci. Lett. 332:2002;159-162.
22. Rademacher D.J., Anders K.A., Riley M.G., Nesbitt J.T., Steinpreis R.E. Determination of the place conditioning and locomotor effects of amperozide in rats: a comparison with cocaine. Exp. Clin. Psychopharmacol. 8:2000;434-443.
23. Ren Y.H., Zhang K.G. Effect of l-tetrahydropalmatine on discrimination of methamphetamine in rats. Chin. J. Drug Depend. 9:2000;108-111.
24. Rezayof A., Zarrindast M.R., Sahraei H., Haeri-Rohani A. Involvement of dopamine D2 receptors of the central amygdala on the acquisition and expression of morphine-induced place preference in rat. Pharmacol. Biochem. Behav. 74:2002;187-197.
25. Seeman P., Watanabe M., Grigoriadis D., Tedesco J.L., George S.R., Svensson U.et al. Dopamine D2 receptor binding sites for agonists. A tetrahedral model. Mol. Pharmacol. 28:1985;391-399.
26. Seiler M.P., Stoll A.P., Closse A., Frick W., Jaton A., Vigouret J.M. Structure-activity relationships of dopaminergic 5-hydroxy-2-aminotetralin derivatives with functionalized N-alkyl substituents. J. Med. Chem. 29:1986;912-917.
27. Shippenberg T.S., Hertz A. Place preference conditioning reveals the involvement of D1-dopamine receptors in the motivational properties of mu- and κ-opioid agonists. Brain Res. 436:1987;169-172.
28. Shippenberg T.S., Hertz A. Motivational effects of opioids: influence of D-1 versus D-2 receptor antagonists. Eur. J. Pharmacol. 151:1988;233-242.
29. Shippenberg T.S., Bals-Kubik R., Herz A. Examination of the neurochemical substrates mediating the motivational effects of opioids: role of the mesolimbic dopamine system and D-1 vs. D-2 dopamine receptors. J. Pharmacol. Exp. Ther. 265:1993;53-59.
30. Smith J.W., Fetsko L.A., Xu R., Wang Y. Dopamine D2L receptor knockout mice display deficits in positive and negative reinforcing properties of morphine and in avoidance learning. Neuroscience. 113:2002;755-765.
31. Spyraki C., Fibiger H.C., Phillips A.G. Attenuation of heroin reward in rats by disruption of the mesolimbic dopamine system. Psychopharmacology. 79:1983;278-283.
32. Spyraki C., Kazandjian A., Varonos D. Diazepam-induced place preference conditioning: appetitive and antiaversive properties. Psychopharmacology. 87:1985;225-232.
33. Suzuki T., Misawa M. Sertindole antagonizes morphine-, cocaine-, and methamphetamine-induced place preference in the rat. Life Sci. 57:1995;1277-1284.
34. Suzuki T., Takamori K., Misawa M., Onodera K. Effects of the histaminergic system on the morphine-induced conditioned place preference in mice. Brain Res. 675:1995;195-202.
35. Tzschentke T.M. Measuring reward with the conditioned place preference paradigm: a comprehensive review of drug effects, recent progress and new issues. Prog. Neurobiol. 56:1998;316-672.
36. Tzschentke T.M., Schmidt W.J. Interactions of MK-801 and GYKI 52466 with morphine and amphetamine in place preference conditioning and behavioural sensitization. Behav. Brain Res. 84:1997;99-107.
37. Wise R.A. Drug-activation of brain reward pathways. Drug. Alcohol Depend. 51:1998;13-22.
38. Zhang X.X., Jin G.Z. (-)-Stepholidine vs. 12-chloroscoulerine enantiomers on firing activity of substantia nigral dopamine neurons. Acta Pharmacol. Sin. 17:1996;18-22.